Liposuction denials in California external review

In the California DMHC record, independent physician reviewers decided 37 published external-review cases involving Liposuctionand overturned the plan’s denial in 21.6%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
37
2002–2025
Overturned
21.6%
8 denials reversed

Conditions behind Liposuction denials

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Lipedema11
9.1%
Gynecomastia7
42.9%
Lipodystrophy4
25%
Typical time to a decision
21 days
Most land between 15 and 21 days
Handled as urgent
18.9%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for bilateral mastectomy and liposuction procedure (CPT 19300 and 15877). Arya and colleagues state that, “True gynecomastia refers to enlarged glandular tissue rather than deposition of fat tissue. Enlargement of breast due to deposition of fat in the breast area is known as pseudogynecomastia.” The authors noted that, “The aims of surgery are: (a) To eliminate painful breast tissue. (b) To restore the patient’s chest to acceptable cosmetic shape. The most commonly used technique is subcutaneous mastectomy that involves direct resection of the glandular tissue using a peri-areolar or trans-areolar approach, with or without liposuction.” Per the American Society of Plastic Surgeons (ASPS), the requested bilateral mastectomy and liposuction procedure are not medically necessary.
Medical Necessity · 2021 · IMR MN21-35484
Findings: The physician reviewer found that The patient has requested authorization and coverage for liposuction surgery. Warren Peled and Kappos state, “Lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, women also describe pain in the lower extremities, particularly with pressure, as well as easy bruising. Although the condition is well described, it is relatively rare and often misdiagnosed.” The authors further note, “Distinguishing lipedema from other conditions causing fatty excess in the lower extremities can be difficult.
Medical Necessity · 2022 · IMR MN22-36981

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for lipedema and panniculectomy surgeries.The authors of a study stated that lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, patients also describe pain in the lower extremities, particularly with pressure, as well as easy bruising. One of the major distinguishing features of lipedema is the sparing of the feet, which can create a distinct step-off at the ankle.
Medical Necessity · 2024 · IMR MN24-42229
Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for Stage 1 lipedema surgical procedure (bilateral lower extremity, posterior trunk, buttock shelf and/or bilateral upper arms and Stage 2 lipedema surgical procedure (bilateral lower extremity, anterior, trunk, abdomen and/or excision of excessive skin and tissue.Medical literature indicates that lipedema is an extremely common disease believed to affect 11% to 39% of the female Caucasian population worldwide and 16 million females in the U.S. Studies noted that lipedema is a disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss.
Medical Necessity · 2023 · IMR MN23-38990

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this treatment generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving Liposuction, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Denied Liposuction? Use the California record to prepare.

Explain my denial — freeStart my appeal · $39